444 related articles for article (PubMed ID: 8137298)
21. Stem cell factor production by human marrow stromal fibroblasts.
Linenberger ML; Jacobson FW; Bennett LG; Broudy VC; Martin FH; Abkowitz JL
Exp Hematol; 1995 Sep; 23(10):1104-14. PubMed ID: 7544739
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous and inducible production of leukaemia inhibitory factor by human bone marrow stromal cells.
Lorgeot V; Rougier F; Fixe P; Cornu E; Praloran V; Denizot Y
Cytokine; 1997 Oct; 9(10):754-8. PubMed ID: 9344507
[TBL] [Abstract][Full Text] [Related]
23. 5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells.
Jazwiec B; Mahon FX; Pigneux A; Pigeonnier V; Reiffers J
Exp Hematol; 1995 Dec; 23(14):1509-14. PubMed ID: 8542939
[TBL] [Abstract][Full Text] [Related]
24. Release of leukemia inhibitory factor in primate sepsis. Analysis of the role of TNF-alpha.
Jansen PM; de Jong IW; Hart M; Kim KJ; Aarden LA; Hinshaw LB; Taylor FB; Hack CE
J Immunol; 1996 Jun; 156(11):4401-7. PubMed ID: 8666813
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor alpha in human long-term bone marrow cultures: distinct effects on nonadherent and adherent progenitors.
Khoury E; Lemoine FM; Baillou C; Kobari L; Deloux J; Guigon M; Najman A
Exp Hematol; 1992 Sep; 20(8):991-7. PubMed ID: 1380463
[TBL] [Abstract][Full Text] [Related]
26. IL-1 inhibits B cell differentiation in long term bone marrow cultures.
Dorshkind K
J Immunol; 1988 Jul; 141(2):531-8. PubMed ID: 3260256
[TBL] [Abstract][Full Text] [Related]
27. Leukemia inhibitory factor concentrations in the bone marrow plasma of healthy subjects and patients with hematologic malignancies.
Lorgeot V; Trimoreau F; Gachard N; Praloran V; Denizot Y
Eur Cytokine Netw; 1997 Mar; 8(1):57-9. PubMed ID: 9110149
[TBL] [Abstract][Full Text] [Related]
28. Constitutive and modulated cytokine expression in two permanent human bone marrow stromal cell lines.
Thalmeier K; Meissner P; Reisbach G; Hültner L; Mortensen BT; Brechtel A; Oostendorp RA; Dörmer P
Exp Hematol; 1996 Jan; 24(1):1-10. PubMed ID: 8536785
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development.
Neben S; Donaldson D; Fitz L; Calvetti J; Neben T; Turner K; Hirayama F; Ogawa M
Exp Hematol; 1996 Jun; 24(7):783-9. PubMed ID: 8647228
[TBL] [Abstract][Full Text] [Related]
30. Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progression.
Wetzler M; Kurzrock R; Lowe DG; Kantarjian H; Gutterman JU; Talpaz M
Blood; 1991 Nov; 78(9):2400-6. PubMed ID: 1932751
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor.
Vargas SJ; Naprta A; Glaccum M; Lee SK; Kalinowski J; Lorenzo JA
J Bone Miner Res; 1996 Nov; 11(11):1736-44. PubMed ID: 8915781
[TBL] [Abstract][Full Text] [Related]
32. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
33. Action of recombinant human interleukin 6, interleukin 1 beta and tumor necrosis factor alpha on the mRNA induction of acute-phase proteins.
Andus T; Geiger T; Hirano T; Kishimoto T; Heinrich PC
Eur J Immunol; 1988 May; 18(5):739-46. PubMed ID: 2454192
[TBL] [Abstract][Full Text] [Related]
34. In vitro production of leukemia inhibitory factor (LIF) by Hep G2 hepatoblastoma cells.
Mezzasoma L; Biondi R; Benedetti C; Floridi C; Ciurnelli R; Falcinelli F; Onorato M; Scaringi L; Marconi P; Rossi R
J Biol Regul Homeost Agents; 1993; 7(4):126-32. PubMed ID: 8023700
[TBL] [Abstract][Full Text] [Related]
35. Leukemia inhibitory factor involvement in human ulcerative colitis and its potential role in malignant course.
Guimbaud R; Abitbol V; Bertrand V; Quartier G; Chauvelot-Moachon L; Giroud J; Couturier D; Chaussade DC
Eur Cytokine Netw; 1998 Dec; 9(4):607-12. PubMed ID: 9889404
[TBL] [Abstract][Full Text] [Related]
36. Role of mitogen-activated protein kinase family in serum-induced leukaemia inhibitory factor and interleukin-6 secretion by bone marrow stromal cells.
Nakao T; Kim S; Ohta K; Kawano H; Hino M; Miura K; Tatsumi N; Iwao H
Br J Pharmacol; 2002 Aug; 136(7):975-84. PubMed ID: 12145097
[TBL] [Abstract][Full Text] [Related]
37. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines.
Chabaud M; Fossiez F; Taupin JL; Miossec P
J Immunol; 1998 Jul; 161(1):409-14. PubMed ID: 9647250
[TBL] [Abstract][Full Text] [Related]
38. Human carcinoma cell lines produce biologically active leukemia inhibitory factor (LIF).
Kamohara H; Sakamoto K; Ishiko T; Mita S; Masuda Y; Abe T; Ogawa M
Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):131-40. PubMed ID: 7994557
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4.
Sillaber C; Bevec D; Butterfield JH; Heppner C; Valenta R; Scheiner O; Kraft D; Lechner K; Bettelheim P; Valent P
Exp Hematol; 1993 Aug; 21(9):1271-5. PubMed ID: 8330651
[TBL] [Abstract][Full Text] [Related]
40. Human interleukin DA-1a (HILDA)/LIF,G-CSF, IL-1 beta, IL-6, and TNF alpha production during acute kidney graft rejection episodes.
Blancho G; Moreau JF; Chabannes D; Chatenoud L; Soulillou JP
Transplant Proc; 1993 Feb; 25(1 Pt 2):891-2. PubMed ID: 7680169
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
